van Klei 2007.
Study characteristics | ||
General information | Objective
Journal
Country
Study design
|
|
Participants | Number of included patients
Surgical specialty
Age
Male sex
High‐risk surgery
Insulin‐dependent diabetes mellitus
History of ischaemic heart disease
History of congestive heart failure
History of cerebrovascular events
Elevated creatinine
0 RCRI factors
1 RCRI factor
2 RCRI factors
3 or more RCRI factors
|
|
Predictors | Predictor 1: Left bundle branch block on ECG
Predictor 2: Right bundle branch block on ECG
Predictor 3: Male gender
|
|
Outcome | Outcome category
Full outcome definition
Prediction horizon
|
|
Analysis | Number of outcomes
Handling missing data
Discrimination reported?
Calibration reported?
Reclassification reported?
|
|
PROBAST: Applicability | Domain 1: Participant selection
Justification: patient selection was appropriate and generalisable to the population used in the RCRI development study Domain 2: Predictors
Justification: predictor definitions were clearly defined and comparable to the definitions used in the development study Domain 3: Outcome
Justification: outcome is myocardial infarction and not MACE Overall judgement
Justification: patient selection was appropriate and predictor definitions were clearly defined and comparable to definitions used in the development study. However, the outcome used was different from MACE in the development study. |
|
Notes | — | |
Item | Authors' judgement | Support for judgement |
Domain 1: Participant selection | Yes | Appropriate participant selection in which patients were selected in whom the RCRI model can be applied. |
Domain 2: Predictors | Yes | Clear (RCRI) predictor definitions were described. |
Domain 3: Outcome | No | Troponin, ECG and echocardiography were not measured in all patients, only on clinical indication. |
Domain 4: Analysis | No | Low number of outcomes, complete case analysis and no reporting on calibration and reclassification measures. |
Overall judgement | No | Patient selection was appropriate. Predictors were clearly defined and assessed. However, troponin, ECG and echocardiography were only measured on clinical indication. In addition, the number of outcomes was low, complete case analysis and no calibration was reported. |